Functional blockade of opioid analgesia by orphanin FQ/nociceptin

Biochemical Pharmacology

Volumn 55, Issue 9, 1998, Pages 1537-1540

  King, Michael ^a   Chang, Albert ^a   Pasternak, Gavril W ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Analgesia; Anti opioid; KOR 3; Morphine; Opioid receptor

Indexed keywords

3,4 DICHLORO N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; MESYLIC ACID; MORPHINE; MORPHINE DERIVATIVE; NALOXONE; NOCICEPTIN; OPIATE AGONIST; OPIATE ANTAGONIST; OPIATE RECEPTOR;

ARTICLE; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; HYPERALGESIA; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING;

ANALGESIA; ANALGESICS, OPIOID; ANIMALS; CEREBRAL VENTRICLES; ENKEPHALIN, D-PENICILLAMINE (2,5)-; ENKEPHALINS; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; MORPHINE; MORPHINE DERIVATIVES; NERVE TISSUE PROTEINS; OLIGONUCLEOTIDES, ANTISENSE; OPIOID PEPTIDES; PEPTIDE FRAGMENTS; RECEPTORS, OPIOID; RECEPTORS, OPIOID, KAPPA;

EID: 0032499420     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(98)00023-9     Document Type: Article

References (34)

1. 3-related opioid receptor using antisense oligodeoxynucleotides. Regul Pept. 54:1994;217-218.
2. 3-related opioid receptor. Mol Pharmacol. 47:1995;1180-1188.
3. Fukuda K, Kato S, Mori K, Nishi M, Takeshima H, Iwabe N, Miyata T, Houtani T, Siguimoti T. cDNA cloning and regional distribution of a novel member of the opioid receptor family. FEBS Lett. 343:1994;42-46.
4. Keith D Jr, Maung T, Anton B, Evans C. Isolation of cDNA clones homologous to opioid receptors. Regul Pept. 54:1994;143-144.
5. Mollereau C, Parmentier M, Mailleux P, Butour JL, Moisand C, Chalon P, Caput D, Vassart G, Meunier JC. ORL-1, a novel member of the opioid family Cloning, functional expression and localization . FEBS Lett. 341:1994;33-38.
6. Uhl GR, Childers S, Pasternak GW. An opiate-receptor gene family reunion. Trends Neurosci. 17:1994;89-93.
7. Wang JB, Johnson PS, Imai Y, Persico AM, Ozenberger BA, Eppler CM, Uhl GR. cDNA cloning of an orphan opiate receptor gene family member and its splice variant. FEBS Lett. 348:1994;75-79.
8. Bunzow JR, Saez C, Mortrud M, Bouvier C, Williams JT, Low M, Grandy DK. Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a μ, δ or κ opioid receptor type. FEBS Lett. 347:1994;284-288.
9. Lachowicz JE, Shen Y, Monsma FJ Jr, Sibley DR. Molecular cloning of a novel G protein-coupled receptor related to the opiate receptor family. J Neurochem. 64:1995;34-40.
10. Wick MJ, Minnerath SR, Lin X, Elde R, Law P-Y, Loh HH. Isolation of a novel cDNA encoding a putative membrane receptor with high homology to the cloned μ, δ, and κ opioid receptors. Mol Brain Res. 27:1994;37-44.
11. Chen Y, Fan Y, Liu J, Mestek A, Tian M, Kozak CA, Yu L. Molecular cloning, tissue distribution and chromosomal localization of a novel member of the opioid receptor gene family. FEBS Lett. 347:1994;279-283.
12. 3-related opiate receptor. Ann NY Acad Sci. 757:1995;332-338.
13. Pasternak GW, Standifer KM. Mapping of opioid receptors using antisense oligodeoxynucleotides Correlating their molecular biology and pharmacology . Trends Pharmacol Sci. 16:1995;344-350.
14. Reinscheid RK, Nothacker H-P, Bourson A, Ardati A, Henningsen RA, Bunzow JR, Grandy DK, Langen H, Monsma FJ Jr, Civelli O. Orphanin FQ A neuropeptide that activates an opioidlike G protein-coupled receptor . Science. 270:1995;792-794.
15. 1 receptor. Nature. 377:1995;532-535.
16. Mogil JS, Grisel JE, Zhangs G, Belknap JK, Grandy DK. Functional antagonism of μ-, δ- and kappa-opioid antinociception by orphanin FQ. Neurosci Lett. 214:1996;131-134.
17. Mogil JS, Grisel JE, Reinscheid RK, Civelli O, Belknap JK, Grandy DK. Orphanin FQ is a functional anti-opioid peptide. Neuroscience. 75:1996;333-337.
18. Rossi G, Leventhal L, Boland E, Pasternak GW. Pharmacological characterization of orphanin FQ/nociceptin and its fragments. J Pharmacol Exp Ther. 282:1997;858-865.
19. King MA, Rossi GC, Chang AH, Williams L, Pasternak GW. Spinal analgesic activity of orphanin FQ/nociceptin and its fragments. Neurosci Lett. 223:1997;113-116.
20. Xu XJ, Hao JX, Wiesenfeld-Hallin Z. Nociceptin or antinociceptin Potent spinal antinociceptive effect of orphanin FQ/nociceptin in the rat . Neuroreport. 7:1996;2092-2094.
21. 1) receptor agonist, on the thermal hyperalgesia induced by unilateral constriction injury to the sciatic nerve in the rat. Neurosci Lett. 224:1997;107-110.
22. Luke MC, Hahn EF, Price M, Pasternak GW. Irreversible opiate agonists and antagonists V. Hydrazone and acylhydrazone derivatives of naltrexone . Life Sci. 43:1988;1249-1256.
23. Haley TJ, McCormick WG. Pharmacological effects produced by intracerebral injections of drugs in the conscious mouse. Br J Pharmacol. 12:1957;12-15.
24. 3-related opioid receptor. Gene. 171:1996;255-260.
25. Standifer KM, Chien C-C, Wahlestedt C, Brown GP, Pasternak GW. Selective loss of δ opioid analgesia and binding by antisense oligodeoxynucleotides to a δ opioid receptor. Neuron. 12:1994;805-810.
26. Standifer KM, Jenab S, Su W, Chien C-C, Pan Y-X, Inturrisi CE, Pasternak GW. Antisense oligodeoxynucleotides to the cloned δ receptor, DOR-1 Uptake, stability and regulation of gene expression . J Neurochem. 65:1995;1981-1987.
27. Grisel JE, Mogil JS, Belknap JK, Grandy DK. Orphanin FQ acts as a supraspinal, but not a spinal, anti-opioid peptide. Neuroreport. 7:1996;2125-2129.
28. Rossi GC, Standifer KM, Pasternak GW. Differential blockade of morphine and morphine-6β-glucuronide analgesia by antisense oligodeoxynucleotides directed against MOR-1 and G-protein α subunits in rats. Neurosci Lett. 198:1995;99-102.
29. Rossi GC, Pan Y-X, Brown GP, Pasternak GW. Antisense mapping the MOR-1 opioid receptor Evidence for alternative splicing and a novel morphine-6β-glucuronide receptor . FEBS Lett. 369:1995;192-196.
30. Standifer KM, Rossi GC, Pasternak GW. Differential blockade of opioid analgesia by antisense oligodeoxynucleotides directed against various G-protein α subunits. Mol Pharmacol. 50:1996;293-298.
31. Brown GP, Yang K, King MA, Rossi GC, Leventhal L, Chang A, Pasternak GW. 3-Methoxynaltrexone, a selective heroin/morphine-6β-glucuronide antagonist. FEBS Lett. 412:1997;35-38.
32. Rossi GC, Brown GP, Leventhal L, Yang K, Pasternak GW. Novel receptor mechanisms for heroin and morphine-6β-glucuronide analgesia. Neurosci Lett. 216:1996;1-4.
33. Rossi GC, Leventhal L, Pan YX, Cole J, Su W, Bodnar RJ, Pasternak GW. Antisense mapping of MOR-1 in rats Distinguishing between morphine and morphine-6β-glucuronide antinociception . J Pharmacol Exp Ther. 281:1997;109-114.
34. Mathis JP, Ryan-Moro J, Chang A, Hom JSH, Scheinberg DA, Pasternak GW. Biochemical evidence for orphanin FQ/nociceptin receptor heterogeneity in mouse brain. Biochem Biophys Res Commun. 230:1997;462-465.